Targeting Mitochondrial Dysfunction

Our lead product, Imeglimin, is in Phase 3 development in Japan and has successfully completed Phase 2 development in the U.S. and EU.

View Candidate
Targeting Mitochondrial Dysfunction

Innovative Pipeline of First-In-Class Products

Our candidates are based on disease-modifying mechanisms of action that offer the potential for safer and more effective therapies for type 2 diabetes and NASH.

View Pipeline
Innovative Pipeline of First-In-Class Products

Backed by Strong Leadership

Our highly-experienced clinical and regulatory teams possess the know-how and experience to successfully develop products within our pipeline.

Meet Our Team
Backed by Strong Leadership

Latest News

Poxel Successfully Raises €17.7 Million in a Capital Increase

LYON, France--(BUSINESS WIRE)--POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes…

Read this Press Release: Poxel Successfully Raises €17.7 Million in a Capital Increase

Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases

PXL770, a novel direct AMPK activator, produced additive benefits in a NASH model when combined with other late-stage agents in development PXL770 treatment was observed to improve cardio-renal disease and…

Read this Press Release: Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases

Poxel Announces Notice of its Annual General Meeting to be Held on June 24, 2020

LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and…

Read this Press Release: Poxel Announces Notice of its Annual General Meeting to be Held on June 24, 2020
Click here to show the previous slide Click here to show the next slide

Upcoming Events

Jefferies Virtual Healthcare Conference

European Association for the Study of the Liver 2020 International Liver Congress

Click here to show the previous slide Click here to show the next slide